The Roadmap to Commercialising Indigenous Knowledge Systems: Where Does Your Innovation Journey Begin?

Every successful innovation begins with an idea.

Sometimes that idea emerges from years of scientific research in a laboratory. Sometimes it grows from an entrepreneur identifying an unmet market need. Across Africa, however, some of the most valuable innovations begin much earlier, through generations of Indigenous Knowledge passed from one community to another, refined over centuries through observation, experience, and practice.

Today, this knowledge represents one of Africa’s greatest untapped innovation opportunities. Traditional medicinal plants, natural health products, cosmetics, agricultural practices, animal health remedies, and indigenous foods all have the potential to become commercially successful products that improve lives, create businesses, generate employment, and strengthen the continent’s growing bioeconomy.

Yet one important question determines whether many of these innovations ultimately succeed or fail.

What is the right pathway to commercialisation?

It is tempting to think that commercialisation begins once scientific research has been completed or a prototype has been developed. In reality, the journey starts much earlier. The decisions made during the earliest stages of research often determine how much funding will be required, how long development will take, which regulations will apply, what intellectual property can be protected, who the customers will be, and whether investors are likely to support the opportunity.

In other words, commercial success is rarely determined by the quality of the innovation alone. It is shaped by the strategy chosen from the very beginning.

This is particularly true for Indigenous Knowledge Systems (IKS). Unlike many conventional technologies, Indigenous Knowledge often exists at the intersection of science, culture, biodiversity, regulation, ethics, and community participation. Commercialising this knowledge requires balancing scientific validation with respect for cultural heritage, ensuring compliance with Access and Benefit-Sharing (ABS) legislation, protecting biodiversity, and creating meaningful economic opportunities for the communities whose knowledge underpins the innovation.

At the same time, innovators must navigate an increasingly complex commercial landscape. Should a traditional medicinal plant become a registered herbal medicine? Would it be better positioned as a complementary medicine or dietary supplement? Could it reach the market more quickly as a cosmetic ingredient? Might it create greater impact as an agricultural product or veterinary solution? Or could it become a novel food that responds to growing consumer demand for natural, functional, and sustainable ingredients?

Each of these pathways offers unique opportunities. Each also carries different regulatory requirements, development timelines, investment needs, commercial risks, and market opportunities. Choosing the wrong pathway can significantly increase development costs, delay market entry, or even prevent an otherwise promising innovation from reaching consumers.

There is no universal answer.

The most successful commercialisation strategies begin by understanding both the innovation and the market it seeks to serve. A product intended for formal healthcare markets may justify the investment required for medicine registration. A wellness product may achieve greater commercial success as a complementary medicine. A botanical extract may build an internationally recognised consumer brand as a cosmetic ingredient, while another innovation may find its greatest opportunity within sustainable agriculture or the rapidly growing functional food sector.

This is why commercialisation should never be viewed simply as a regulatory exercise. It is a strategic process that integrates science, intellectual property, market demand, manufacturing, regulation, funding, sustainability, and community participation into a single commercial vision.

At Maravion we believe that successful Indigenous Knowledge commercialisation begins long before a product reaches the market. Through commercialisation strategy, market assessment, techno-economic analysis, regulatory planning, intellectual property valuation, business planning, and investor readiness support, we help innovators identify the pathway most likely to achieve both commercial success and meaningful social impact.

Over the next five articles, we will explore the major commercialisation pathways available for Indigenous Knowledge Systems. We examine the opportunities, challenges, regulatory considerations, development timelines, and strategic implications of developing herbal and traditional medicines, complementary medicines and dietary supplements, cosmetics and personal care products, agricultural and animal health products, and novel foodstuffs.

Every Indigenous Knowledge innovation follows its own journey. Understanding the available pathways is the first step towards ensuring that the destination is not only scientifically credible, but also commercially successful, ethically grounded, and capable of delivering lasting value for innovators, investors, Indigenous communities, and society.

The journey begins with choosing the right path.